StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by sleepydog1on Mar 09, 2019 8:21pm

222 Views

Post# 29465879

RE:Staging for a major run

Totally reminds me of SX run also as I was in at .10 for 1.5 million shares and road it to $2.90 in a month ... GEN on the other hand has reason to be at $2.90 and this time I'm gonna ride 2.8 million shares to the top ... Love this company and what it can do to change peoples lives ... f$%# Cancer ... SD1

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale